eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.78% | 1.40% | 13.14% | -20.95% | -426.30% |
| Total Depreciation and Amortization | 0.00% | 11.11% | 44.44% | 800.00% | 460.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.90% | -16.65% | -30.37% | 58,750.00% | 112.96% |
| Change in Net Operating Assets | -60.41% | 115.63% | -269.50% | -157.93% | 255.13% |
| Cash from Operations | 4.70% | 17.91% | 5.24% | -93.60% | -17.55% |
| Capital Expenditure | -- | -315.38% | 95.56% | 63.64% | 77.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -169.92% | 147.59% | -152.15% | -147.63% | 132.04% |
| Cash from Investing | -170.02% | 146.99% | -152.86% | -149.67% | 131.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,875.47% | -- | 208.11% | -- | -92.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,613.21% | 16,610.81% | 208.11% | 34,790.48% | -92.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.49% | 397.00% | -109.62% | 435.93% | 105.00% |